Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Ramatroban
Introduction
Ramatroban (INN) is a thromboxane receptor antagonist indicated for the treatment of coronary artery disease.[1] It has also been used for the treatment of asthma.[2]
It was developed by the German pharmaceutical company Bayer AG and is co-marketed in Japan by Bayer and Nippon Shinyaku Co. Ltd. under the tradename Baynas.
References
- ↑ Fiedler VB, Seuter F, Perzborn E (1990). “Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease”. Stroke. 21 (12 Suppl): IV149–51. PMID 2260140. Unknown parameter
|month=ignored (help) - ↑ Endo S, Akiyama K (1996). “[Thromboxane A2 receptor antagonist in asthma therapy]”. Nippon Rinsho (in Japanese). 54 (11): 3045–8. PMID 8950952. Unknown parameter
|month=ignored (help)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]